Skip to main content
. 2020 May 14;18:48. doi: 10.1186/s12958-020-00597-w

Table 1.

Baseline characteristics according to endometrial thickness at trigger day

≤7.6 mm
(n = 109)
7.7–13.0 mm
(n = 798)
≥13.1 mm
(n = 109)
P-value
Maternal age (years) 30.7 ± 3.7 30.2 ± 3.7 30.0 ± 3.3 0.313
Maternal BMI (kg/m2) 21.76 ± 2.56 22.34 ± 3.35 22.13 ± 2.87 0.401
Paternal age (years) 32.9 ± 5.4 32.1 ± 4.4 32.1 ± 4.9 0.465
Paternal BMI (kg/m2) 25.09 ± 2.95 24.50 ± 3.08 24.35 ± 3.21 0.224
Nulligravida, n (%) 53 (48.6) 551 (69.0) 90 (82.6) < 0.001
Nulliparity, n (%) 101 (92.7) 761 (95.4) 103 (94.5) 0.465
Duration of infertility (years) 2.8 ± 1.8 2.9 ± 2.0 3.0 ± 2.2 0.828
Infertility diagnosis, n (%) 0.610
 Anovulation 19 (17.4) 143 (17.9) 16 (14.7)
 Male factor 21 (19.3) 192 (24.1) 28 (25.7)
 Endometriosis 0 (0) 18 (2.3) 3 (2.8)
  Mixed 3 (2.8) 26 (3.3) 5 (4.6)
 Unexplained 66 (60.6) 419 (52.5) 57 (52.3)
Rank of IUI attempts, n (%) 0.652
 1st cycle 70 (64.2) 485 (60.8) 61 (56.0)
 2nd cycle 30 (27.5) 246 (30.8) 35 (32.1)
 3rd or more 9 (8.3) 67 (8.4) 13 (11.9)
Stimulation protocol, n (%) 0.661
 LE 13 (11.9) 79 (9.9) 9 (8.3)
 LE + hMG 96 (88.1) 719 (90.1) 100 (91.7)
Length of treatment (days) 10.3 ± 2.0 11.5 ± 2.9 12.5 ± 2.7 < 0.001
Peak E2 level (pg/mL) 256.6 ± 197.9 287.9 ± 205.8 346.3 ± 248.7 < 0.001
Endometrial thickness (mm) 6.60 ± 0.96 10.06 ± 1.43 14.42 ± 1.27 < 0.001
Postprocessing TMSC (millions) 27.8 ± 27.4 32.6 ± 37.4 33.2 ± 33.8 0.430
Vanishing twin syndrome, n (%) 4 (3.7) 15 (1.9) 2 (1.8) 0.469
Pregnancy complications, n (%) 7 (6.4) 60 (7.5) 9 (8.3) 0.875
Year of treatment 0.131
 2008–2011 6 (5.5) 72 (9.0) 14 (12.8)
 2012–2015 39 (35.8) 345 (43.2) 43 (39.4)
 2016–2018 64 (58.7) 381 (47.7) 52 (47.7)

Data are presented as mean ± standard deviation or number (percentage).

BMI body mass index, IUI intrauterine insemination, LE letrozole, hMG human menopausal gonadotropin, E2 estradiol, TMSC total motile sperm count